Issue
Combined detection of CEA and CA125 for the diagnosis for lung cancer: A meta-analysis
Corresponding Author(s) : Li-xin Wu
Cellular and Molecular Biology,
Vol. 64 No. 15: Issue 15
Abstract
This study aimed to systematically evaluate the value of combined detection of serum CEA and CA125 concentrations for the diagnosis of lung cancer. Related studies regarding the diagnosis of lung cancer were searched in PubMed, Embase, CNKI, and Wanfang using a computer. The number of patients who were true-positive, false-positive, false-negative, and true-negative were extracted from each study. Meta-analysis was performed using the Meta-Disc l.4, RevMan 5.3. Seven studies involving 2,216 cases were finally included. Regarding the diagnosis of lung cancer, the sensitivity, specificity, and diagnostic odds ratio of combined CEA and CA125 detection were higher than those of CEA detection alone. The area under the curve (AUC) of combined detection was 0.90, whereas the independently detected AUC was 0.73. Combined CEA and CA125 detection has higher diagnostic efficiency for lung cancer than CEA detection alone. The significance of combined serum CEA and CA125 detection in lung cancer is confirmed.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- Sriram KB, Larsen JE, Yang IA, Bowman RV, Fong KM. Genomic medicine in non-small cell lung cancer: Paving the path to personalized care. Respirology 2011; 16:257-263.
- Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, et al. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Am J Clin Oncol 2008; 31:133-139.
- Gupta JK, Chien PF, Voit D, Li A. Ultrasonographic endomertrial thickness for diagnosing test into a summary ROC curve: Data-analytic approaches and some additional considerations. Health Technol Assess 2005; 9:1-113.
- Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002; 21:1237-1256.
- Liu YX, Wang JZ, Liu JP, Li A. Meta analysis in the application of diagnostic test evaluation. Chinese Journal of Health Statistics 2005; 22:16-19.
- Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12:1293-1316.
- Zeng C, Quan GL, Wamg CL, Li A. Combined detection of six serum tumor markers in the diagnosis for lung cancer. Guangdong Med 2012; 33:808-810.
- Chen F, Li WM, Wang DM, Gao CS, Bao Y, Chen WB, et al. The value of detecting serum tumor markers together in lung cancer diagnosis. Journal of Sichuan University (medical edition) 2008; 5:832-835.
- Zhang HY, Li A. The application of CEA and CA125 in diagnosis of lung cancer. Medical Laboratory Science and Clinices 2013; 10:3335-3336.
- Ye HY, Han SS, Ye YL, Li A. The diagnostic value of CA125 and CEA on non-small cell lung cancer. Journal of Clinical Hematology (Blood transfusion and testing) 2016; 29:479-481.
- Cai JK, Shi WJ, Gao TM, Li A. Clinical value of serum tumor markers in non-small cell lung cancer. Jiangsu Medicine 2003; 3:191-192.
- Ma L, Xie XW, Wang HY, Ma LY, Wen ZG. Clinical evaluation of tumor markers for diagnosis in patients with non-small cell lung cancer in china. Asian Pac J Cancer Prev 2015; 16:4891-4894.
- Yao YC, Li A. The clinical application value of CA125, CYFRA21-1 and CEA in non-small cell lung cancer. Clinical and clinical trials 12:1659-1660.
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11-30.
- Jan CR, Lu YC, T Seng LL. Effect of the antidepressant desipramine on cytosolic (Ca2+): Movement and proliferation in human ostcosarcoma cells. Pharmacology 2003; 69:190-196.
- GOLD P, Freedman S. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121:439-462.
- Ni J, Guo ZJ, Zhang L, Li A. The value of four lung cancer serum tumor markers in lung cancer diagnosis by single and combined detection. Chinese Journal of Internal Medicine 2016; 55:25-30.
- Lee S, Lee CY, Kim DJ, Li A. Pathologic correlation of serum carcinoembryonic antigen and cytokeratin 19 fragment in resected nonsmall cell lung cancer. Korean J Thorac Cardiovasc Surg 2013; 46:192-196.
- Vitone LJ, Greenhalf W, Howes NR. Hereditary pancreatitis and secondary screening for early pancreatic cancer. Rocz Akad Med Bialymst 2011; 50:73-84.
References
Sriram KB, Larsen JE, Yang IA, Bowman RV, Fong KM. Genomic medicine in non-small cell lung cancer: Paving the path to personalized care. Respirology 2011; 16:257-263.
Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, et al. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Am J Clin Oncol 2008; 31:133-139.
Gupta JK, Chien PF, Voit D, Li A. Ultrasonographic endomertrial thickness for diagnosing test into a summary ROC curve: Data-analytic approaches and some additional considerations. Health Technol Assess 2005; 9:1-113.
Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002; 21:1237-1256.
Liu YX, Wang JZ, Liu JP, Li A. Meta analysis in the application of diagnostic test evaluation. Chinese Journal of Health Statistics 2005; 22:16-19.
Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12:1293-1316.
Zeng C, Quan GL, Wamg CL, Li A. Combined detection of six serum tumor markers in the diagnosis for lung cancer. Guangdong Med 2012; 33:808-810.
Chen F, Li WM, Wang DM, Gao CS, Bao Y, Chen WB, et al. The value of detecting serum tumor markers together in lung cancer diagnosis. Journal of Sichuan University (medical edition) 2008; 5:832-835.
Zhang HY, Li A. The application of CEA and CA125 in diagnosis of lung cancer. Medical Laboratory Science and Clinices 2013; 10:3335-3336.
Ye HY, Han SS, Ye YL, Li A. The diagnostic value of CA125 and CEA on non-small cell lung cancer. Journal of Clinical Hematology (Blood transfusion and testing) 2016; 29:479-481.
Cai JK, Shi WJ, Gao TM, Li A. Clinical value of serum tumor markers in non-small cell lung cancer. Jiangsu Medicine 2003; 3:191-192.
Ma L, Xie XW, Wang HY, Ma LY, Wen ZG. Clinical evaluation of tumor markers for diagnosis in patients with non-small cell lung cancer in china. Asian Pac J Cancer Prev 2015; 16:4891-4894.
Yao YC, Li A. The clinical application value of CA125, CYFRA21-1 and CEA in non-small cell lung cancer. Clinical and clinical trials 12:1659-1660.
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11-30.
Jan CR, Lu YC, T Seng LL. Effect of the antidepressant desipramine on cytosolic (Ca2+): Movement and proliferation in human ostcosarcoma cells. Pharmacology 2003; 69:190-196.
GOLD P, Freedman S. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121:439-462.
Ni J, Guo ZJ, Zhang L, Li A. The value of four lung cancer serum tumor markers in lung cancer diagnosis by single and combined detection. Chinese Journal of Internal Medicine 2016; 55:25-30.
Lee S, Lee CY, Kim DJ, Li A. Pathologic correlation of serum carcinoembryonic antigen and cytokeratin 19 fragment in resected nonsmall cell lung cancer. Korean J Thorac Cardiovasc Surg 2013; 46:192-196.
Vitone LJ, Greenhalf W, Howes NR. Hereditary pancreatitis and secondary screening for early pancreatic cancer. Rocz Akad Med Bialymst 2011; 50:73-84.